Spark PLUS B488a,,cents anti-human CD137 (4-1BB) [4B4-1]

BioLegend Inc. was awarded a contract by the University of Virginia on August 8, 2026, for the supply of laboratory reagents and biologics. The contract pertains to the delivery of Spark PLUS B488a anti-human CD137 (4-1BB) monoclonal antibody, a research-grade immunological reagent commonly utilized in flow cytometry and cellular analysis applications. The single line item award specifies a quantity of one unit at a unit price of $261.10, with delivery directed to Paul Woodman Wright at the contracting organization.

The total contract value is $261.10, representing a routine procurement of specialized biological research materials by the University of Virginia, a state institution in Virginia. This award reflects a standard transactional purchase of reagent materials for research purposes. No extended performance period, annual value, or cumulative contract duration information beyond the award date of August 8, 2026, has been documented in the procurement record.